- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2016
- Public Summary Document (PSD) July 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2016 PBAC Meeting - Word
Lenvatinib – July 2016
Lenvatinib: 4 mg capsule, 30, 10 mg capsule, 30, Lenvima®
Last updated
28 October 2016